1Julie Louise Gerberding, M D, M P H. Management of occupational exposures to blood-borne viruses[ J ]. N Engl J Med, 1995.332:444 -449.
2John G Bartlett. MEDICAL CARE of PATIENTS WITH HIV INFECTION.Eighth Edition[J] .Williams & Wilkins, 1999.77 - 78.
3Henderson DK, Fahey BJ, Willy M. et al. Risk for occupational transmission of human immunodeficiency virus type 1 associated with clinical exposures.A prospective evaluation. [J ] Ann Intern Med, 1990,113:740-746.
4CDC. Public Health Service statement on management of occupational exposures human immunodeficiency virus, including considerations regarding zidovudine postexposure use[J ], . MMWR 1990, 39(RR-1 ) :1- 14.
5Jerome I.Tokars, MD, MPH; Ruthanne Marcus, MPH; David H.Culver, PHD; Charles A.Schable, MS et al.Surveillance of HIV Infection and Zidoudine Use among Health Care Workers after occupational exposure to HIV-infected Blood[J] .Ann Intern Med, 1993,118:913-918.
6Beekmann SE, Fahey BJ, Gerberding JL, et al.Risky business: using necessarily imprecise casualty counts to estimate occupational risks for HIV-1 infection[J]. Infect Control Hosp Epidemiol, 1990;11:371 -379.
